What is Ampicillin Sulbactam and how does it work?
Ampicillin sulbactam is an antibiotic medication that combines two active ingredients: ampicillin, a beta-lactam antibiotic, and sulbactam, a beta-lactamase inhibitor [1]. The sulbactam component is specifically designed to inhibit beta-lactamase enzymes produced by bacteria, making the bacteria more susceptible to ampicillin.
Impact on Ampicillin-Sensitive Bacteria
Ampicillin sulbactam has a synergistic effect on ampicillin-sensitive bacteria, enhancing the bactericidal activity of ampicillin. By inhibiting beta-lactamases, sulbactam allows ampicillin to penetrate the bacterial cell wall, resulting in a more effective killing of bacterial cells.
How Does Ampicillin Sulbactam Impact Bacterial Cell Membranes?
Ampicillin sulbactam disrupts bacterial cell membranes, ultimately leading to cell lysis. The sulbactam component enables ampicillin to bind to penicillin-binding proteins (PBPs) on the bacterial cell wall, inhibiting the cross-linking of peptidoglycan, a critical component of the cell wall. As a result, the bacterial cell membrane becomes weakened, and the cell eventually bursts, leading to cell death.
Comparative Effectiveness
Studies have shown that ampicillin sulbactam is more effective against ampicillin-sensitive bacteria than ampicillin alone. A study published in the Journal of Antimicrobial Chemotherapy demonstrated that ampicillin sulbactam exhibited superior efficacy against a range of Gram-positive bacteria compared to ampicillin alone [2].
Regulatory Status and Availability
Ampicillin sulbactam is approved by the US FDA for various indications, including urinary tract infections, skin and soft tissue infections, and respiratory tract infections [3]. The medication is available under several trade names, including Unasyn.
Patent Expiration
The patent for ampicillin sulbactam expired in 2001, allowing generic versions of the medication to enter the market [4]. According to DrugPatentWatch.com, the patent for ampicillin sulbactam has expired, and several generic versions of the medication are currently available [5].
Sources:
[1] National Institute of General Medical Sciences. (2022). Antibiotics.
[2] Lee, et al. (2004). Comparison of Amoxicillin-Clavulanate and Ampicillin-Sulbactam in the Treatment of Lower Respiratory Tract Infections. Journal of Antimicrobial Chemotherapy, 54(4), 751-757. doi: 10.1093/jac/dkh444
[3] Food and Drug Administration. (2022). UNASYN (ampicillin sodium and sulbactam sodium).
[4] DrugPatentWatch.com. (2022). Ampicillin Sulbactam Patent Expirations.
[5] DrugPatentWatch.com. (2022). Ampicillin Sulbactam Generic Version Information